The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
Open accessAbstract
AIMS: Vernakalant is a novel, relatively atrial-selective antiarrhythmic agent for conversion of atrial fibrillation (AF) to sinus rhythm. This study examined the safety and efficacy of vernakalant in converting atrial flutter (AFL) to sinus rhythm. METHODS AND RESULTS: This was a phase 2/3, randomized, double-blind, placebo-controlled trial. Adults with AFL received either a 10 min infusion of 3.0 mg/kg vernakalant (n = 39) or placebo (n = 15). If AFL or AF persisted at the end of a 15 min observation period, a second 10 min infusion of 2.0 mg/kg vernakalant or placebo was administered. The primary efficacy outcome was the proportion of patients who had treatment-induced conversion of AFL to sinus rhythm for a minimum duration of 1 min within 90 min after the start of the first infusion. No patient in the placebo group met the primary outcome. Only one patient receiving vernakalant (1 of 39, 3%) converted to sinus rhythm. A reduced mean absolute ventricular response rate occurred within 50 min in patients receiving vernakalant (mean change from baseline -8.2 b.p.m.) vs. patients receiving placebo (-0.2 b.p.m.) (P = 0.037). A post-hoc analysis revealed that vernakalant increased AFL cycle length by an average of 55 ms, whereas the AFL cycle length was unchanged in the placebo group (P < 0.001). There was no occurrence of 1 : 1 atrio-ventricular conduction. Dysgeusia and sneezing were the most common treatment-related adverse events, consistent with previous reports. CONCLUSION: Vernakalant did not restore sinus rhythm in patients with AFL. Vernakalant modestly slowed AFL and ventricular response rates, and was well tolerated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blomstrom-Lundqvist (2003) · doi:10.1161/01.cir.0000091380.04100.84 · Cited by 955
Singh, S., Zoble, R. G., Yellen, L., Brodsky, M. A., Feld, G. K., Berk, M., & Billing, C. B. (2000) · Circulation · doi:10.1161/01.cir.102.19.2385 · Cited by 433
Incidence and predictors of atrial flutter in the general population
Granada, J., Uribe, W., Chyou, P.-H., Maassen, K., Vierkant, R., Smith, P. N., Hayes, J., Eaker, E., & Vidaillet, H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00982-7 · Cited by 375
Bianconi, L. (2000) · European Heart Journal · doi:10.1053/euhj.1999.2039 · Cited by 126
Research works printed but not linked: 22
- 2010, Clinical Medicine & Research, 8, 1, 10.3121/cmr.2009.851 · DOI
- Waldo, 2008, Journal of the American College of Cardiology, 51, 779, 10.1016/j.jacc.2007.08.066 · DOI · Paper page
- Ng, 2008, Mayo Clinic Proceedings, 83, 646, 10.4065/83.6.646 · doi:10.4065/83.6.646
- 2008, Circulation, 117, 1101, 10.1161/CIRCULATIONAHA.107.187192 · DOI
- Dobrev, 2010, Lancet, 375, 1212, 10.1016/S0140-6736(10)60096-7 · DOI · Paper page
- CHIMIENTI, 1995, European Heart Journal, 16, 1943, 10.1093/oxfordjournals.eurheartj.a060852 · DOI
- Fedida, 2005, Journal of cardiovascular electrophysiology, 16, 1227, 10.1111/j.1540-8167.2005.50028.x · DOI · Paper page
- Dorian, 2007, Journal of cardiovascular pharmacology, 50, 35, 10.1097/FJC.0b013e3180547553 · DOI
- 2008, Circulation, 117, 1518, 10.1161/CIRCULATIONAHA.107.723866 · DOI · Paper page
- Roy, 2004, Journal of the American College of Cardiology, 44, 2355, 10.1016/j.jacc.2004.09.021 · DOI
- Pratt, 2010, The American journal of cardiology, 106, 1277, 10.1016/j.amjcard.2010.06.054 · doi:10.1016/j.amjcard.2010.06.054
- 2009, Circulation: Arrhythmia and Electrophysiology, 2, 652, 10.1161/CIRCEP.109.870204 · DOI · Paper page
- 1920, Heart, 7, 353
- 1920, Acta medica Scandinavica, 53, 469, 10.1111/j.0954-6820.1920.tb18266.x · DOI · Paper page
- Glatter, 2001, Circulation, 103, 253, 10.1161/01.CIR.103.2.253 · DOI
- VanderLugt, 1999, Circulation, 100, 369, 10.1161/01.CIR.100.4.369 · DOI · Paper page
- Volgman, 1998, Journal of the American College of Cardiology, 31, 1414, 10.1016/S0735-1097(98)00078-3 · DOI · Paper page
- Writing Committee Members, 2006, Europace, 8, 651, 10.1093/europace/eul097 · DOI · Paper page
- Hellestrand, 1982, Heart, 48, 140, 10.1136/hrt.48.2.140 · DOI
- 2011, Europace, 13, 161, 10.1093/europace/euq382 · DOI · Paper page
- Falk, 1992, Annals of Internal Medicine, 117, 141, 10.1059/0003-4819-117-2-141 · doi:10.1059/0003-4819-117-2-141
- Kawabata, 2001, Journal of electrocardiology, 34, 65, 10.1054/jelc.2001.22034 · DOI
Cited by
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,822
Self-citation2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,899
Self-citationAndrade, J. G., Aguilar, M., Atzema, C., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 562
Self-citationHusted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0403 · Cited by 364
Sanders, P., Pürerfellner, H., Pokushalov, E., Sarkar, S., Di Bacco, M., Maus, B., & Dekker, L. R. C. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.03.005 · Cited by 162
Metadata
- Authors
- Camm, A. J., Toft, E., Torp-Pedersen, C., Vijayaraman, P., Juul-Moller, S., Ip, J., Beatch, G. N., Dickinson, G., Wyse, D. G., & for the Scene 2 Investigators
- Venue
- Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-29
- Volume
- 14
- Issue
- 6
- Pages
- 804-809
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- OpenAlex
- W2112991023
- Cited by
- 159
- References
- 4
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1093/europace/eur416
- The paper
- Camm, A. J., Toft, E., Torp-Pedersen, C., Vijayaraman, P., Juul-Moller, S., Ip, J., Beatch, G. N., Dickinson, G., Wyse, D. G., & for the Scene 2 Investigators. (2012). Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial. Europace. https://doi.org/10.1093/europace/eur416
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.